Fiscal Period | 2025 | 2024 | 2023 | 2022 |
---|---|---|---|---|
Period End Date | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
Issuance( Retirement)of Debt Net | 2.81 | -1.57 | 1.45 | -1.48 |
Net Changein Cash | -0.05 | 0.03 | 0.09 | -0.01 |
Cash Taxes Paid | 0.01 | 0.15 | 0.12 | 0.00 |
Net Income/ Starting Line | -0.67 | 0.70 | 0.72 | 0.33 |
Changesin Working Capital | -2.20 | 0.92 | -2.08 | 1.72 |
Cashfrom Operating Activities | -2.50 | 2.04 | -0.95 | 2.47 |
Cash Interest Paid | 0.35 | 0.41 | 0.42 | 0.41 |
Cashfrom Financing Activities | 2.46 | -1.98 | 1.03 | -2.48 |
Depreciation/ Depletion | 0.01 | 0.01 | 0.00 | 0.01 |
Other Investing Cash Flow Items Total | 0.00 | 0.00 | 0.00 | 0.00 |
Capital Expenditures | -0.01 | -0.04 | 0.00 | 0.00 |
period Type | - | - | - | - |
Non- Cash Items | 0.35 | 0.41 | 0.42 | 0.41 |
Financing Cash Flow Items | -0.35 | -0.41 | -0.42 | -1.00 |
period Length | 12.00 | 12.00 | 12.00 | 12.00 |
Cashfrom Investing Activities | -0.01 | -0.04 | 0.00 | 0.00 |
Vivanza Biosciences Dividend Vivanza Biosciences Bonus Vivanza Biosciences News Vivanza Biosciences AGM Vivanza Biosciences Rights Vivanza Biosciences Splits Vivanza Biosciences Board Meetings Vivanza Biosciences Key Metrics Vivanza Biosciences Shareholdings Vivanza Biosciences Profit Loss Vivanza Biosciences Balance Sheet Vivanza Biosciences Q1 Results Vivanza Biosciences Q2 Results Vivanza Biosciences Q3 Results Vivanza Biosciences Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks